TriageGO is a software tool that leverages machine learning to suggest an acuity-level at triage, based on the likelihood of various ED (emergency department) outcomes. The tool supports the nurse by providing an actionable data point and, combined with their own clinical judgement, enables the nurse to sort patients into the correct trajectories for care in the Emergency Department. TriageGO empowers the clinician to better-differentiate patients based on their clinical risk, and in doing so, has impactful operational benefits; decreasing time-to-provider, time-to-emergent care for high-risk patients, and time-to-discharge across the board. TriageGO is seamlessly embedded within the EHR (Epic & Cerner) so that it is not disruptive to the clinician's workflow.

• eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognition of patients requiring increased medical attention. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts likelihood of critical illness onset, hours before it happens.
• eCART received FDA 510(k) clearance in 2024, with clinical performance data of nearly two million hospitalizations from 21 hospitals, including an unprecedented level of real-world prospective data, to ensure consistent accuracy across geography, age, race, and top medical conditions (e.g. sepsis, COPD, heart failure). 
• Built upon more than a decade of ongoing scientific research, eCART was developed at UChicago Medicine by Dr. Dana Edelson, MD, MS and Dr. Matthew Churpek, MD, PhD and is well chronicled in published literature. The analytic and workflow have been in use in clinical practice since 2016.

At AgileMD, we are building the most advanced real-time predictive analytics and clinical pathways platform for hospitals.

To date, AgileMD tools have been used on more than 4 million patient encounters by more than 135,000 clinical users in over 250 hospitals, including some of the nation's leading academic medical centers. AgileMD's eCART clinical deterioration prediction software is FDA cleared and the first AI-powered early warning device for ward patients to go through the FDA process with real-world prospective data. 

AgileMD is backed by premier start-up partners MATTER, YCombinator, and Rock Health, and our cutting-edge analytics are built on more than decade of ongoing research at the University of Chicago. In 2021, AgileMD garnered nearly $3 million in combined federal research and development funding from the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA).

TriageGO embodies the principles of Open Innovation fostered by EHRs like Epic & Cerner who support an app-market-style ecosystem. While some risk-predictive features exist within current EHRs, there is no comparable solution for risk-stratification at triage, trained on the data within that hospital's instance of the EHR. 

There is one similar product on the market known as KATE from Mednition. This product still relies in the resource-based ESI methodology of triage. One hospital using KATE reported just 65% accuracy in triage asignment. In an evaluation done at Johns Hopkins, where TriageGO was invented, the tool demonstrated 78% sensitivity to identify patients who went on to need critical care, and a 120% improvement over ESI to identify those who went on to need an emergency procedure. It was also observed that using TriageGO, the rate of low-acuity patients who were ultimately hospitalized went from 6% to 3%. 

• Continuously monitors EHR data in real time
• Stratifies hospitalized patients by risk of impending all-cause clinical deterioration and sepsis
• Notifies inpatient providers when patient may need additional assessment and management
• Recommends clinical pathways with integrated order entry

• Authorized: FDA 510(k) cleared
• Tested: Derived and validated in nearly 3 million patient encounters across 28 hospitals
• Experienced: 8+ years in clinical use; 10+ years of published academic literature on value over other early warning scores
• Accurate: High sensitiviy and specificity, meaning fewer false alarms and more efficient focus on the highest risk patients
• Integrated: Embedded cross-team workflow ensures that risk scores are not ignored and action is taken
• Benchmarked: Robust reporting, benchmarking, and implementation support drive quality improvement